Shiraj Sen M.D., Ph.D., is board certified in internal medicine and medical oncology. Dr. Sen's research interest is in developing new, promising drugs to treat cancer through phase I clinical trials. Dr. Sen leads the phase I clinical trial group at NEXT Oncology Dallas. Dr. Sen is committed to providing his patients access to the newest cancer treatment options available through phase I clinical trials when standard treatments are no longer effective for them.
Experience
Education
Fellowship in Medical Oncology and Hematology
The University of Texas MD Anderson Cancer Center, Houston, TX
Residency in Internal Medicine
The University of Texas Southwestern Medical Center, Dallas, TX
Medical Doctorate
The University of Texas Medical School at Houston, Houston, TX
Doctor of Philosophy in Biomedical Sciences
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX
